TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1 Prevalence of Key Disease Indications (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers Etc.) forKey Countries/Region 4.2 Recent Industry Developments such as Partnerships,Mergers & Acquisitions 4.3 New Product Launches 4.4 Regulatory Framework by Key Countries 4.5 Reimbursement Scenario, Key Countries 4.6 Economic Cost Burden For The Treatment Of Chronic Wounds By Key Countries/ Region 5. Global Active Wound Care Market Analysis, Insights and Forecast, 2014-2025 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Product Type 5.2.1 Biological Skin Equivalents 5.2.1.1 Allografts 5.2.1.2 Xenografts 5.2.1.3 Cell-based Therapies 5.2.2 Growth Factors 5.2.2.1 Epidermal Growth Factors 5.2.2.2 Platelet-derived Growth Factors 5.2.2.3 Others 5.2.3 Biological Dressings 5.2.3.1 Collagen Dressings 5.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.) 5.2.4 Others 5.3. Market Analysis, Insights and Forecast – By Indication 5.3.1 Diabetic Foot Ulcers 5.3.2 Pressure Ulcers 5.3.3 Lower Limb Ulcers 5.3.4 Others 5.4. Market Analysis, Insights and Forecast – By End User 5.4.1 Hospitals 5.4.2 Clinics 5.4.3 Home Care Settings 5.4.4 Others 5.5. Market Analysis, Insights and Forecast – By Region 5.5.1 North America 5.5.2 Europe 5.5.3 Asia Pacific 5.5.4 Latin America 5.5.5 Middle East & Africa 6. North America Active Wound Care Market Analysis, Insights and Forecast, 2014-2025 6.1. Key Findings / Summary 6.2. Market Analysis, Insights and Forecast – By Product Type 6.2.1 Biological Skin Equivalents 6.2.1.1 Allografts 6.2.1.2 Xenografts 6.2.1.3 Cell-based Therapies 6.2.2 Growth Factors 6.2.2.1 Epidermal Growth Factors 6.2.2.2 Platelet-derived Growth Factors 6.2.2.3 Others 6.2.3 Biological Dressings 6.2.3.1 Collagen Dressings 6.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.) 6.2.4 Others 6.3. Market Analysis, Insights and Forecast – By Indication 6.3.1 Diabetic Foot Ulcers 6.3.2 Pressure Ulcers 6.3.3 Lower Limb Ulcers 6.3.4 Others 6.4. Market Analysis, Insights and Forecast– By End User 6.4.1 Hospitals 6.4.2 Clinics 6.4.3 HomeCare Settings 6.4.4 Others 6.5. Market Analysis, Insights and Forecast – By Country 6.5.1 U.S. 6.5.2 Canada 7. Europe Active Wound Care Market Analysis, Insights and Forecast, 2014-2025 7.1. Key Findings / Summary 7.2. Market Analysis, Insights and Forecast– By Product Type 7.2.1 Biological Skin Equivalents 7.2.1.1 Allografts 7.2.1.2 Xenografts 7.2.1.3 Cell-based Therapies 7.2.2 Growth Factors 7.2.2.1 Epidermal Growth Factors 7.2.2.2 Platelet-derived Growth Factors 7.2.2.3 Others 7.2.3 Biological Dressings 7.2.3.1 Collagen Dressings 7.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.) 7.2.4 Others 7.3. Market Analysis, Insights and Forecast – By Indication 7.3.1 Diabetic Foot Ulcers 7.3.2 Pressure Ulcers 7.3.3 Lower Limb Ulcers 7.3.4 Others 7.4. Market Analysis, Insights and Forecast – By End User 7.4.1 Hospitals 7.4.2 Clinics 7.4.3 Home Care Settings 7.4.4 Others 7.5. Market Analysis, Insights and Forecast – By Country/ Sub-region 7.5.1 Germany 7.5.2 U.K. 7.5.3 France 7.5.4 Italy 7.5.5 Spain 7.5.6 Scandinavia 7.5.7 Rest of Europe 8. Asia Pacific Active Wound Care Market Analysis, Insights and Forecast, 2014-2025 8.1. Key Findings / Summary 8.2. Market Analysis, Insights and Forecast – By Product Type 8.2.1 Biological Skin Equivalents 8.2.1.1 Allografts 8.2.1.2 Xenografts 8.2.1.3 Cell-based Therapies 8.2.2 Growth Factors 8.2.2.1 Epidermal Growth Factors 8.2.2.2 Platelet-derived Growth Factors 8.2.2.3 Others 8.2.3 Biological Dressings 8.2.3.1 Collagen Dressings 8.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.) 8.2.4 Others 8.3. Market Analysis, Insights and Forecast – By Indication 8.3.1 Diabetic Foot Ulcers 8.3.2 Pressure Ulcers 8.3.3 Lower Limb Ulcers 8.3.4 Others 8.4. Market Analysis, Insights and Forecast – By End User 8.4.1 Hospitals 8.4.2 Clinics 8.4.3 Home Care Settings 8.4.4 Others 8.5. Market Analysis, Insights and Forecast – By Country/ Sub-region 8.5.1 China 8.5.2 India 8.5.3 Japan 8.5.4 Australia 8.5.5 South East Asia 8.5.6 Rest of Asia Pacific 9. Latin America Active Wound Care Market Analysis, Insights and Forecast, 2014-2025 9.1. Key Findings / Summary 9.2. Market Analysis, Insights and Forecast – By Product Type 9.2.1 Biological Skin Equivalents 9.2.1.1 Allografts 9.2.1.2 Xenografts 9.2.1.3 Cell-based Therapies 9.2.2 Growth Factors 9.2.2.1 Epidermal Growth Factors 9.2.2.2 Platelet-derived Growth Factors 9.2.2.3 Others 9.2.3 Biological Dressings 9.2.3.1 Collagen Dressings 9.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.) 9.2.4 Others 9.3. Market Analysis, Insights and Forecast – By Indication 9.3.1 Diabetic Foot Ulcers 9.3.2 Pressure Ulcers 9.3.3 Lower Limb Ulcers 9.3.4 Others 9.4. Market Analysis, Insights and Forecast – By End User 9.4.1 Hospitals 9.4.2 Clinics 9.4.3 Home Care Settings 9.4.4 Others 9.5. Market Analysis, Insights and Forecast– By Country/ Sub-region 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Rest of Latin America 10. Middle East &Africa Active Wound Care Market Analysis, Insights and Forecast, 2014-2025 10.1. Key Findings / Summary 10.2. Market Analysis, Insights and Forecast– By Product Type 10.2.1 Biological Skin Equivalents 10.2.1.1 Allografts 10.2.1.2 Xenografts 10.2.1.3 Cell-based Therapies 10.2.2 Growth Factors 10.2.2.1 Epidermal Growth Factors 10.2.2.2 Platelet-derived Growth Factors 10.2.2.3 Others 10.2.3 Biological Dressings 10.2.3.1 Collagen Dressings 10.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.) 10.2.4 Others 10.3. Market Analysis, Insights and Forecast – By Indication 10.3.1 Diabetic Foot Ulcers 10.3.2 Pressure Ulcers 10.3.3 Lower Limb Ulcers 10.3.4 Others 10.4. Market Analysis, Insights and Forecast – By End User 10.4.1 Hospitals 10.4.2 Clinics 10.4.3 Home Care Settings 10.4.4 Others 10.5. Market Analysis, Insights and Forecast – By Country/ Sub-region 10.5.1 South Africa 10.5.2 GCC 10.5.3 Rest of Middle East & Africa 11. Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2017) 11.3. Company Profiles (Overview,Products & services, SWOT analysis, Recent developments, strategies,financials (based on availability)) 11.3.1 MiMedx 11.3.2 TissueRegenix 11.3.3 Smith& Nephew 11.3.4 Organogenesis Inc. 11.3.5 AcellInc. 11.3.6 Integra Life Sciences 11.3.7 Solsys Medical 11.3.8 Osiris Therapeutics, Inc. 12. Strategic Recommendations

MiMedx Tissue Regenix Smith & Nephew Organogenesis Inc. Acell Inc. Integra Life Sciences Solsys Medical Osiris Therapeutics, Inc. Other Prominent Players